Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Tweet
Print
Mohammed Milhem, MBBS
Clinical Professor
University of Iowa
Poster(s):
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
